---

Market Overview

---

The APAC pharmaceutical packaging market, valued at $16.96 billion in 2022, is expected to reach $22.81 billion by 2028, exhibiting a compound annual growth rate (CAGR) of 5.06% during the study period.

Pharmaceutical packaging encompasses the processes involved in packaging pharmaceutical preparations and is an essential component of pharmaceutical products. Packaging not only facilitates dosing, dispensing, and use of the pharmaceutical product but also plays a crucial role in ensuring the safety of the drug. It is important that the materials used for drug packaging remain inert and do not react with the packaged drug.

In response to growing environmental concerns, many pharmaceutical companies are transitioning towards sustainable packaging methods that utilize recyclable materials and biodegradable plastics. The adoption of sustainable pharmaceutical packaging has the potential to bring about significant positive changes. As more companies recognize their impact on the environment, they are likely to move away from non-recyclable or non-degradable products. Several companies have found viable alternatives for sustainable packaging in the form of 100% organic or 100% recycled plastic materials.

Recent years have witnessed advancements in nanomaterials and nanotechnologies applied in the pharmaceutical industry. Some companies have developed nanotechnology-based authentication and anti-counterfeiting technologies for pharmaceutical packaging. These technologies help combat counterfeit drugs and prevent their distribution outside of intended markets. The integration of nanotechnology into pharmaceutical packaging serves as an important tool in the fight against counterfeiting.

The pharmaceutical industry is undergoing transformation due to increasing healthcare demands and advancements in technology. With the elderly population projected to double to over 1.5 billion people by 2050, there is a growing prevalence of chronic conditions. Patients often experience multiple ailments, leading to an increased demand for pharmaceuticals. Consequently, the pharmaceutical packaging market is driven by the rising demand for pharmaceutical products in response to the evolving healthcare landscape.

---

Market Segmentation

---

The market is segmented based on various factors, including type, material, end-user, and geography.

Segmentation by Type
Primary – Blister Packs, Bottles, Vials, Ampoules, Others
Secondary
Tertiary

Segmentation by Material
Paper
Glass
Plastic
Others

Segmentation by End-User
Pharmaceutical Companies
CMO/ CDMO
Plastic

Segmentation by Geography
China
Japan
South Korea
India
Australia

The APAC pharmaceutical packaging market is primarily driven by the demand for various primary packaging solutions such as blister packs, bottles, vials, ampoules, pouches, sachets, and bags. Primary packaging holds the highest market share of over 70% due to the increasing demand for pharmaceutical products.

Among the primary packaging types, the strips and blister packaging segment dominates with a market share of more than 33%. This segment is widely used as an essential primary packaging element for pharmaceutical products, contributing to its dominance over other segments.

In terms of material type, the paper segment holds a market share of over 39% in the APAC pharmaceutical packaging market. This can be attributed to the high demand for recyclable materials in secondary and tertiary packaging.

The pharmaceutical and biotech companies are the major end-users in the APAC pharmaceutical packaging market, accounting for more than 45% of the market share. This is driven by factors such as the growing aging population, increasing demand for branded drugs, over-the-counter drugs, specialty medicines, expiring patents, and higher drug prices.

In terms of geographical distribution, China holds a significant market share of 26.93% in the APAC pharmaceutical packaging market in 2022, followed by Japan with 20.97% and South Korea with 16.44%. This can be attributed to factors such as a high aging population, a high prevalence of chronic diseases, increasing demand for prescription drugs, the presence of leading pharmaceutical players, well-developed infrastructure, and significant investments in drug development.

---

Competitive Landscape

---

The pharmaceutical packaging market is characterized by intense competition. As healthcare becomes increasingly digitalized, numerous small and mid-sized companies are entering the market to expand their presence in this rapidly growing sector. Furthermore, the focus on the development and exploration of advanced technologies has enabled key players to attract a large customer base. In the APAC region, the competition in the pharmaceutical packaging market is fierce, with several global players offering a wide range of products. Some of the leading companies currently dominating the APAC pharmaceutical packaging market include Amcor, Aptar Group, Berry Global, Gerresheimer AG, and WestRock Pharmaceuticals.

Key companies profiled in this report include Amcor, Aptar Group, Berry Global, Gerresheimer AG, WestRock Pharmaceuticals, ACG, Airnov, BD, Bilcare Research, CCL, Borosil, Drug Plastic Group, DWK Life Sciences, LOG, Meghmani Group, Nolato, Nemera, Polycine, Renolit, Specialty Polyfilms, Vetter, West Pharmaceuticals, Wihuri Group, Comar, Constantia, KP, Nipro, Medical Packaging Inc, Bandall.

---

Key Questions Answered

---

What is the market size of the APAC Pharmaceutical Packaging market?
What are the most recent trends observed in the APAC Pharmaceutical Packaging market?
Who are the major players in the APAC Pharmaceutical Packaging market?
Which end-user type segment holds the largest share in the APAC Pharmaceutical Packaging market?
Which packaging type segment has the highest market share in the pharmaceutical packaging market?
Which APAC country has the largest market share in the pharmaceutical packaging market?
How is each segment of the market projected to grow during the forecast period?